1 / 16

Jeffery Wong, Clinical Research Coordinator, Nucleus Network Ltd

T16 Phase I studies – Phase I units and you, a Phase I unit’s expectation – A Day in the Life of a Phase I Study Coordinator. Jeffery Wong, Clinical Research Coordinator, Nucleus Network Ltd. A Day in The Life of A Study Coordinator. Main objectives:

althea
Télécharger la présentation

Jeffery Wong, Clinical Research Coordinator, Nucleus Network Ltd

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. T16 Phase I studies – Phase I units and you, a Phase I unit’s expectation – A Day in the Life of a Phase I Study Coordinator Jeffery Wong, Clinical Research Coordinator, Nucleus Network Ltd

  2. A Day in The Life of A Study Coordinator • Main objectives: • To create awareness and a better understanding of a Phase I clinical research co-ordinator’s (CRC) role • To provide an understanding of the intensity of Phase I clinical trials • To highlight some of the differences between Phase I trials and later phase trials

  3. A Day in The Life of A Study Coordinator Clinical Research Co-ordinator Principal Investigator Commercial Sponsor Ethics Committee Subjects/ Participants Technical/ Study Logistics Recruitment/ Screening Data Management Clinical Trials Pharmacy

  4. A Day in The Life of A Study Coordinator Principal Investigator • Report and discuss any adverse events as well as any subject safety concerns. - Daily updates if conducting MAD study • Provide PI with periodic update on study progress. Ethics Committee • Prepare ethics submission package in conjunction with Project Manager • Provide safety updates, submit amendments and obtain approvals. i.e. fortnightly safety reports. • Provide annual progress reports.

  5. A Day in The Life of A Study Coordinator Commercial Sponsor • Provide updates to Sponsor/CRA pertaining to recruitment and progress of study. • Clarify specific protocol requirements i.e. inclusion/exclusion criteria, study procedures. • Confirm timeline for DSMB and the data required for evaluation. DSMB meetings could be fortnightly. • Provide daily AE and safety lab updates via email. • SAE reporting.

  6. A Day in The Life of A Study Coordinator Recruitment/Screening • Ensure adequate subjects are recruited for each study including availability of alternate subjects. • Up to 4 – 6 volunteers being screened daily • Average screening window is 28 days • Ensure exclusion/inclusion criteria are clear to minimise ratio of screen failures. Patient/Subject • Ensure subjects’ compliance and their understanding of each study’s requirements. • Ensure subjects’ safety and comfort whilst participating in a study i.e. laundry, catering, entertainment etc.

  7. A Day in The Life of A Study Coordinator Technical/Study Logistics • Ensure study related samples i.e. PK, PD and PGx are appropriately processed and shipped to specified destination as indicated in study protocol. • Shipment could occur on the same day after last sample is collected. • Liaise with technical lead to ensure study laboratory requirements are adequate. • Liaise with other contracted laboratories i.e. Melbourne Path, Alfred Path etc. • Short turnaround time for results.

  8. A Day in The Life of A Study Coordinator Clinical Trials Pharmacy • Provide prescriptions to Clinical Trials Pharmacy for dispensing of IP • Dispensing of IP could take place on the morning of dosing. • Ensure proper destruction/return of IP post dosing – IP accountability. Data Management • Ensure completeness of source documentation. • Ensure CRF transcription is performed in a timely manner in accordance with pre-defined timelines. • Ensure open queries are resolved.

  9. A Day in The Life of A Study Coordinator Scenario Study 1: Dosing Day • Very intense with all activities running by the clock. • Triplicate ECGs, Supine/Seated/Standing vitals, multiple blood sampling time points • Every team member needs to know their role and be on stand by to provide assistance. • Every change in circumstances result in a chain reaction i.e. delay in dosing. • Food effect trials have additional concerns i.e. meal times & type of food. • Sponsors may witness dosing or require verbal updates on day of dosing.

  10. A Day in The Life of A Study Coordinator Fig 1. Study Task Pad

  11. A Day in The Life of A Study Coordinator Fig 1. Study Task Pad

  12. A Day in The Life of A Study Coordinator Scenario Study 2: Source notes documentation • Multiple data points due to assessment intensity. • 100 – 200 data points from predose to 1st hr post dose. • Documentation involves entry from multiple study personnel (entire study team). • Medical history and concomitant medication records are usually brief compared to later phase trials i.e. several volumes.

  13. A Day in The Life of A Study Coordinator Fig 2. Source Notes

  14. A Day in The Life of A Study Coordinator Fig 2. Source Notes

  15. A Day in The Life of A Study Coordinator Scenario Study 3: Data Management • QC performed on source documentation prior to being monitored. • More and more sponsors are requesting real time data entry. • CRA may need to come in and perform SDV whilst data is being entered into the CRFs. • Lab results are transferred electronically – dose escalation evaluation. • Tight timeline for query resolution before data base lock.

  16. A Day in The Life of A Study Coordinator Conclusion • Men can multitask too! Old myth is busted. • The success/smooth running of an early phase trial relies heavily on team effort hence clear communication line is imperative. • Early phase trials are intense hence study protocol clarity is essential to ensure expectations could be met. • Main differences between Phase I trials and later phase trials are the intensity and study timelines.

More Related